EUVIMEDEUVIMED entdecken
Open Access

The Tyrosine Kinase Receptor EphA2 in Alveolar Macrophages Provides a Protective Role in Host Defense Against Pneumocystis Pneumonia

Theodore J Kottom iD, Madeline Pellegrino, Conrad C Achilonu iD, Kimberly E Stelzig iD, Andrew H Limper iD

The Journal of Infectious Diseases · 03.08.2026 · 234 (1) · 154-163

DOI: 10.1093/infdis/jiag228 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 23.04.2026. Verfasst von Theodore J Kottom und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, 221 First Street SW, Rochester,…. Hauptthemen laut MEDLINE: Macrophages, Alveolar, Pneumonia, Pneumocystis, Receptor, EphA2. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Mayo Foundation, Walter and Leonore Annenberg Foundation, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Alveolar macrophages (AMs) are central to host defense against Pneumocystis, mediating organism clearance while also contributing to lung inflammation. EphA2, a transmembrane receptor that binds fungal β-glucans, has emerged as a regulator of host–pathogen interactions, but its role in AM responses during Pneumocystis pneumonia (PCP) is unknown.

Methods

We evaluated AM inflammatory responses to Pneumocystis β-glucans in the presence and absence of EphA2. In vivo studies used a CD4-depleted mouse model of PCP comparing wild-type and EphA2-deficient (EphA2−/−) mice. Lung cytokine responses and organism burden were assessed. Additionally, EphA2 signaling was pharmacologically inhibited using ALW-II-41-27 during trimethoprim-sulfamethoxazole treatment.

Results

EphA2 deficiency significantly reduced AM proinflammatory cytokine responses to Pneumocystis β-glucans. In CD4-depleted PCP mice, EphA2−/− animals demonstrated decreased lung inflammatory cytokines, but increased organism burden compared to controls. Pharmacologic inhibition of EphA2 during antimicrobial therapy significantly suppressed lung inflammation.

Conclusions

EphA2 signaling plays a critical role in AM-mediated host defense against Pneumocystis by promoting inflammatory responses necessary for organism control. However, this pathway also contributes to lung inflammation. Targeting EphA2 may represent a novel strategy to modulate inflammation during severe PCP while preserving antimicrobial defense.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macrophages, AlveolarPneumonia, PneumocystisReceptor, EphA2AnimalsMiceCytokinesMice, KnockoutMice, Inbred C57BLLungDisease Models, AnimalPneumocystisSignal Transductionbeta-GlucansHost-Pathogen Interactions

Stichwörter der Autor:innen

PneumocystisEphA2alveolar macrophage (AMs)inflammation

Substanzen

Receptor, EphA2Cytokinesbeta-Glucans

Autor:innen und Institutionen

  • Department of Pulmonary and Critical Care Medicine, Thoracic Diseases Research Unit, Mayo Clinic College of Medicine, 221 First Street SW, Rochester, Minnesota 55905, USA.

ORCID-Profile: Theodore J Kottom, Conrad C Achilonu, Kimberly E Stelzig, Andrew H Limper

Förderung

  • Mayo Foundation
  • Walter and Leonore Annenberg Foundation
  • NIH
  • NHLBI NIH HHS

Zitieren

APA

Kottom, T. J., Pellegrino, M., Achilonu, C. C., Stelzig, K. E., & Limper, A. H. (2026). The Tyrosine Kinase Receptor EphA2 in Alveolar Macrophages Provides a Protective Role in Host Defense Against Pneumocystis Pneumonia. The Journal of Infectious Diseases, 234(1), 154-163. https://doi.org/10.1093/infdis/jiag228

Vancouver

Kottom TJ, Pellegrino M, Achilonu CC, Stelzig KE, Limper AH. The Tyrosine Kinase Receptor EphA2 in Alveolar Macrophages Provides a Protective Role in Host Defense Against Pneumocystis Pneumonia. The Journal of Infectious Diseases. 2026;234(1):154-163. doi:10.1093/infdis/jiag228

BibTeX
@article{Kottom2026,
  author = {Kottom, Theodore J and Pellegrino, Madeline and Achilonu, Conrad C and Stelzig, Kimberly E and Limper, Andrew H},
  title = {The Tyrosine Kinase Receptor EphA2 in Alveolar Macrophages Provides a Protective Role in Host Defense Against Pneumocystis Pneumonia},
  journal = {The Journal of Infectious Diseases},
  year = {2026},
  volume = {234},
  number = {1},
  pages = {154--163},
  doi = {10.1093/infdis/jiag228}
}
Kostenlos starten →